More recently, the knowledge that Alzheimer-associated proteins Tau and APP (discussed earlier) are DYRK1A substrates has attracted the study of DYRK1A inhibitors in neurodegenerative disease in general (77, 78). The gene discussed is DYRK1A; the disease is neurodegenerative disease.